Comparative evaluation of the inhibitory activities of the novel penicillanic acid sulfone Ro 48-1220 against beta-lactamases that belong to groups 1, 2b, and 2be

Author:

Tzouvelekis L S1,Gazouli M1,Prinarakis E E1,Tzelepi E1,Legakis N J1

Affiliation:

1. Department of Bacteriology, Hellenic Pasteur Institute, Athens, Greece.

Abstract

The inhibitory activity of the penicillanic acid sulfone Ro 48-1220 against group 1, 2b, and 2be beta-lactamases was evaluated. Ro 48-1220 inhibited TEM and SHV as effectively as clavulanate and tazobactam. It also inhibited group 1 beta-lactamases at lower concentrations than tazobactam. Ro 48-1220, at a concentration of 4 micrograms/ml, protected ceftriaxone and ceftazidime against strains producing group 1 and 2be beta-lactamases.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference18 articles.

1. Angehrn P. W. Cullmann P. Hohl C. Hubschwerlen H. Richter and R. L. Then. 1994. In vitro activity of ~-lactam antibiotics with Ro 48-1220 a new ~-lactamase inhibitor against ~-lactamase producing bacteria abstr. F153 p. 203. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology Washington D.C.

2. TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum ~-lactamases;Bradford P. A.;Antimicrob. Agents Chemother.,1996

3. A functional classification scheme for ~-lactamases and its correlation with molecular structure;Bush K.;Antimicrob. Agents Chemother.,1995

4. Inhibitors of bacterial ~-lactamases;Cole M.;Drugs Future,1981

5. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and ~-lactamase inhibitor combinations by hyperproduction of SHV-5 ~-lactamases;French G. L.;J. Clin. Microbiol.,1996

Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. β-Lactamase Inhibitors Under Research;Antimicrobial Agents;2014-04-30

2. Multidrug-Resistant Gram-Negative Bacterial Infections: Are you Ready for the Challenge?;Current Clinical Pharmacology;2014-02

3. β-Lactamase Inhibitors: An Update;Mini-Reviews in Medicinal Chemistry;2013-10-01

4. Current Trends in β-Lactam Based β-Lactamases Inhibitors;Current Medicinal Chemistry;2011-09-01

5. New treatment options against gram-negative organisms;Critical Care;2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3